Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics [Yahoo! Finance]
American Oncology Network Appoints New Board Member [Yahoo! Finance]
Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets [Yahoo! Finance]
Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets
Fresenius Medical Care AG (NYSE: FMS) had its price target raised by analysts at Truist Financial Co. from $21.00 to $24.00. They now have a "hold" rating on the stock.